Scaling Excellence: Samsung Biologics’ Vision for the Next Era of Biomanufacturing

  As the biopharmaceutical industry enters a new phase of growth, manufacturers are under increasing pressure to deliver greater capacity, accelerate...

June 23, 2026 | Tuesday | Expert Opinion
The Future of Biologics Demands More Than Capacity—It Demands True Partnership

  During BIO 2026, taking place June 22–25 at the San Diego Convention Center, BioPharma Boardroom spoke with Francisco Man...

June 23, 2026 | Tuesday | Interaction
Advancing Analytical Excellence to Accelerate the Next Generation of Biopharmaceutical Innovation

As biopharmaceutical innovation continues to evolve, analytical science is playing a more strategic role in accelerating development and supporting regulat...

June 23, 2026 | Tuesday | Interaction
Redefining Biologics Partnerships Through Shared Risk and Scientific Collaboration

The biologics development landscape is becoming increasingly complex, requiring partners that offer more than manufacturing capacity alone. As biotech comp...

June 22, 2026 | Monday | Expert Opinion
Enabling the Next Generation of Therapeutics Through Smarter DNA Infrastructure

BIO 2026, taking place June 22–25 at the San Diego Convention Center, arrives at a time when genomic medicine is rapidly reshaping the future of heal...

June 23, 2026 | Tuesday | Interview
Transforming Contamination Control from Compliance Requirement to Strategic Advantage

Contamination control is no longer viewed solely through the lens of compliance. Across today's biopharmaceutical manufacturing landscape, it has become a ...

June 23, 2026 | Tuesday | Interaction
Reimagining Biotech Manufacturing: Enabling Innovation Without Infrastructure Constraints

  BIO 2026, taking place June 22–25 at the San Diego Convention Center, comes at a pivotal moment for emerging biotech companies. While scienti...

June 23, 2026 | Tuesday | Interview
Influencing Early-Phase Success: How Ardena Is Helping Biotechs Turn Complex Science into Clinical Progress

As biotech innovators pursue increasingly complex therapies, the path from discovery to clinical proof of concept is becoming more challenging than ever. F...

June 23, 2026 | Tuesday | News
Kither Biotech Completes First-in-Human Phase 1 Trial of Inhaled Respiratory Therapy KIT2014

First-in-human Phase 1 study in 56 healthy participants demonstrated KIT2014’s safety and tolerability KIT2014 is being developed as an inhalati...

June 22, 2026 | Monday | News
Sonire Therapeutics Secures $13 Million NEDO Grant to Accelerate Commercialization of Ultrasound-Guided HIFU Cancer Therapy

Non-dilutive funding will support the commercialization, development, and expansion strategy for Sonire's Ultrasound-Guided HIFU Platform Sonire Therape...

June 19, 2026 | Friday | News
Olorofim Meets Phase 3 Endpoint in Invasive Aspergillosis, Advancing First Novel Antifungal Mechanism in Over Two Decades

The study achieved the primary endpoint of non-inferiority, with a rate of all-cause mortality (ACM) at Day 42 for olorofim of 23.8% and for AmBisome&r...

June 19, 2026 | Friday | News
Roche’s Subcutaneous Lunsumio VELO Plus Polivy Accepted by FDA for Review in Relapsed or Refractory Large B-Cell Lymphoma

Filing acceptance based on data from the phase III SUNMO study where subcutaneous Lunsumio VELO plus Polivy demonstrated a 59% reduction in risk of dis...

June 19, 2026 | Friday | News
Catalent Launches Qai, Enterprise AI Platform to Advance Quality Management Across Global Manufacturing Network

Catalent, Inc., the leading global contract development and manufacturing organization (CDMO) dedicated to helping people live better and healthier lives...

June 18, 2026 | Thursday | News
IDBS and Alchemi Partner to Accelerate AI-Driven Regulatory Submissions in Biopharma

IDBS, a Danaher company and leading provider of cloud software for biopharma, and Alchemi, a leading applied AI company serving the world's largest pharm...

June 18, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close